According to the Market Statsville Group (MSG), the Global Spirometer Market size is expected to grow from USD 940.8 million in 2021 to USD 2,182.3 million by 2030 at a CAGR of 9.8% from 2022 to 2030. Spirometry equipment is used to diagnose and test for respiratory diseases such as obstructive chronic lung disease, emphysema, asthma, and other breathing disorders in the workplace. In the coming years, the global growth in COPD cases is expected to increase the demand for spirometers. Companies are making spirometers with improved design and features to simplify the difficult procedure of pulmonary function testing for patients and medical professionals. The major goal is to build spirometers with a larger yield and provide better patient comfort without causing complications. In addition, companies are implementing novel packing processes to prevent bacterial infections. Such technological advancements make patient testing procedures easier and more simple.

The market is driven by a growth in the incidence of chronic respiratory disorders, a growing preference for home healthcare, and technological advancements. As per the World Health Organization (WHO), polluted air is inhaled by 90% of the world's population. Pollutants and irritants have various negative effects on the lungs; growing lung diseases have driven the market’s growth.

COVID-19 Impact on the Spirometer Market

During the initial months of the pandemic, pulmonary function tests and planned pulmonary visits were suspended/postponed except in emergencies, according to the recommendations of the New Zealand and Irish Thoracic Societies, the Thoracic Society of Australia, and the American Thoracic Society. In patients with COPD, pneumonia, acute chest syndrome, and other respiratory disorders, incentive spirometry is commonly used. As per the American Journal of Emergency Medicine study in January 2021, researchers and professionals from the University of Illinois at Chicago proposed using incentive spirometry to cure COVID-19 patients with mild to moderate respiratory symptoms.

For some period, the number of patients requiring respiratory support will continue to increase, which augments the demand for spirometers. Increased preference for home healthcare after the pandemic is expected to open new opportunities in the coming future. As a result, various companies are developing spirometers for home use.

Scope of the Spirometer Market

The study categorizes the spirometer marketbased on type, technology, end-use, and application at regional and global levels.

By Type Outlook (Sales, USD Million, 2017-2030)

• Hand Held
• Table Top
• Desktop

By Technology Outlook (Sales, USD Million, 2017-2030)

• Volume Measurement
• Flow Measurement
• Peak Flow Measurement

By Application Outlook (Sales, USD Million, 2017-2030)

• Asthma
• COPD
• Cystic Fibrosis
• Others

By End Use Outlook (Sales, USD Million, 2017-2030)

• Hospitals and Clinics
• Home Healthcare

By Region Outlook (Sales, USD Million, 2017-2030)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Italy
  • France
  • UK
  • Spain
  • Poland
  • Russia
  • Slovenia
  • Slovakia
  • the Netherlands
  • Belgium
  • Norway
  • Denmark
  • Czech Republic
  • Sweden
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Malaysia
  • Thailand
  • Vietnam
  • the Philippines
  • Singapore
  • Australia & New Zealand
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Northern Africa
  • Rest of MEA

Hospitals and clinics segment is projected to account for the largest market share by end-use

Based on end-use, the spirometer market is divided into hospitals and clinics, home healthcare. Spirometry is extensively performed in hospitals and clinics to diagnose and monitor chronic respiratory disorders; hence, hospitals and clinics dominate the spirometer market. Factors driving the segment's growth include a growing aging population, increased reimbursements for hospital clinical tests, and the introduction of advanced devices.

Asia Pacific accounts for the highest CAGR during the forecast period

Based on the regions, the Spirometer Market has been analyzed across five major regions: North America, Asia Pacific, the Middle East & Africa, Europe, and Latin or South America. During the forecast period, Asia Pacific is expected to grow at the highest rates. Improving primary care activities for the early identification and management of chronic lung disorders such as COPD and asthma will foster the Asia Pacific market during the forecast period. Moreover, the region is witnessing high investments from market players in order to expand their business in developing countries like India and China.

Key Market Players in Spirometer Market

The spirometer market is mildly concentrated in nature with few numbers of global players operating in the market, such as:

• Schiller
• Smiths Medical
• Vyaire Medical, Inc.
• SDI Diagnostics
• nSpire Health Inc.
• Fukuda Sangyo Co. Ltd.
• Sibelmed
• Vitalograph
• Geratherm Respiratory AG
• Koninklijke Philips N.V.
• Welch Allyn
• Benson Medical Instruments
• Chest M.I
• Fukuda Sangyo
• Hill-Rom Inc
• Jones Medical Instrument Company
• Medical International Research
• Midmark Corporation
• NDD Medizintechnik AG

Recent Developments

• In April 2021, Vitalograph introduced the next-generation Pneumotrac spirometer in the United States and the Spirotrac 6 software upgrade.
• In March 2021, Vyaire Medical launched the AioCare mobile spirometry system in over 15 countries across Europe, the Middle East, and Australia, thereby expanding their product offering globally.
• In August 2020, Queset Medical, Inc. launched a series of PFT Anti-Viral filters that comply with the most recent spirometry guidelines. The Canadian Respiratory Society, European Respiratory Society, and American Thoracic Society also recommend these filters. Moreover, the US FDA has authorized them to provide 99.9% cross-contamination efficiency.
• In January 2020, the US FDA authorized Air Next, a wireless spirometer developed by NuvoAir. Air Next is meant for at-home usage for patients with chronic obstructive pulmonary disease, cystic fibrosis, and asthma and can also transfer data to Air Next's mobile app.
• In January 2020, NuvoAir announced a partnership with Roche Italy, under which Roche would distribute NuvoAir's digital respiratory technology to cystic fibrosis hospitals throughout Italy. This is expected to increase market competitiveness over the forthcoming period.

Key Issues Addressed

• What is the market size by various segmentation of the spirometer by region and its respective countries?
• What is the customer buying behavior, key takeaways, and Porter's five forces of the spirometer market?
• What are the key opportunities and trends for manufacturers involved in the spirometer supply chain?
• What are the market's fundamental dynamics (drivers, restraints, opportunities, and challenges)?
• What and how are regulations, schemes, patents, and policies impacting the market's growth?
• What are the upcoming technological solutions influencing market trends? How will existing companies adapt to the new change in technology?
• The market player positioning, top winning strategies by years, company product developments, and launches will be?
• How has COVID-19 impacted the demand and sales of spirometer in the global market? Also, the expected BPS drop or rise count of the market and market predicted recovery period.
• Detailed analysis of the competitors and their latest launch, and what are the prominent startups introduced in the target market? Also, detailed company profiling of 25+ leading and prominent companies in the market